Sponsored by Tammy Duckworth (D)
Aviation Medication Transparency Act of 2026
Requires the FAA to publish a list of medications pilots and air traffic controllers can safely use.
Tradeoff
Gives pilots and air traffic controllers clear guidance on which medications are permitted for medical certification. Costs the FAA less than $500,000 over five years to compile and maintain the list.
What's in it
Costs less than $500,000 over the 2026-2031 period, subject to .
The $500K is just the federal cost for the FAA to publish and maintain a medication list — the policy itself imposes no direct federal spending or taxes, and creates no private-sector mandate beyond the FAA's administrative work.
Passed the Senate by on September 24, 2026 — sitting in the House.
Senate
Introduced
(Nov 20, 2025)
Senate
Committee on Commerce, Science, and Transportation(Nov 20, 2025)
Senate
The Committee on Commerce, Science, and Transportation voted to send it to the floor
Reported(Jul 22, 2026)
Committee report S. Rept. 119-140.
Senate
Passage of the bill
Passed by (Sep 24, 2026)
No individual votes were recorded.
House
Received from the Senate
Received(Oct 1, 2026)
- John Hoeven (R-ND)
- Richard J. Durbin (D-IL)
- Katie Boyd Britt (R-AL)
- John W. Hickenlooper (D-CO)
- James E. Risch (R-ID)
- Amy Klobuchar (D-MN)
- Jack Reed (D-RI)
- Andy Kim (D-NJ)
- Jeff Merkley (D-OR)
- Martin Heinrich (D-NM)
- Mark R. Warner (D-VA)
- Jeanne Shaheen (D-NH)
- Christopher A. Coons (D-DE)
- Richard Blumenthal (D-CT)